Armis Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$428K Sell
827
-5
-0.6% -$2.4K 0.04% 297
2026
Q1
$371K Sell
832
-244
-23% -$132K 0.04% 300
2025
Q4
$510K Buy
1,076
+411
+62% +$232K 0.06% 228
2025
Q3
$376K Buy
+665
New +$310K 0.03% 220

Other funds holding TMO

Armis Advisers's TMO Position: Q2 2026 in Review

Armis Advisers reduced its Thermo Fisher Scientific (TMO) stake by 0.6% in Q2 2026, selling an estimated $2.4K and leaving 827 shares worth $428K. The position accounts for 0.04% of the portfolio, ranked #297.

Armis Advisers first reported a position in TMO in Q3 2025 and has held it in 4 quarters since. The position peaked at $510K in Q4 2025. 567 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Armis Advisers held 827 shares of Thermo Fisher Scientific worth $428K as of Q2 2026.
  • Armis Advisers sold 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
  • Thermo Fisher Scientific made up 0.04% of Armis Advisers's portfolio in Q2 2026, its #297 holding.
  • Armis Advisers first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 4 quarters since.
  • Armis Advisers's Thermo Fisher Scientific position peaked at $510K in Q4 2025.
  • 567 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.